Patients with chronic hepatitis C have a chance to prevent the disease. Long-lasting schemes with the use of interferon disappear, which were difficult to perform and do not always bring the desired result. Modern antiviral medicine, for example, Myhep All, stops the replication of the hepatitis C virus.MyHep All is a medicine that is a combination of Velpatasvir & Sofosbuvir (Generic Epclusa) in India. MyHep All, manufactured by Mylan, is indicated to treat chronic Hepatitis C virus infection. Each packet of MyHep All contains 28 tablets, containing 400 mg of Sofosbuvir and 100 mg of Velpatasvir. Before using this medicine, you should always consult your doctor or with a specialist in this section of medicine.